Cross Country Coalitions Must ‘Guarantee Confidential Pricing And Improve Access’
Executive Summary
Industry says that if cross country-coalitions on pricing and reimbursement are to succeed, the member countries need to be similar in terms of GDP and to guarantee pricing is kept confidential.
You may also be interested in...
EFPIA On How To Make Cross-Country Collaborations Work
Cross-country collaboration on pricing and reimbursement will only work if they are based on certain overarching principles, says the European Federation of Pharmaceutical Industries and Associations.
BeNeLuxA Makes First Positive Reimbursement Decision On Biogen’s Spinraza
In a BeNeLuxA first, Belgium and the Netherlands have reached an agreement with Biogen to reimburse rare disease treatment Spinraza after joint health technology assessment and pricing negotiations.
Greece Calls For Sharper Teeth for Valletta Group As Croatia Enlists
The Valletta group of southern EU states on improving access to medicines continues to expand and now includes Croatia.